Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to compare the effectiveness of the combination of
valtorcitabine and telbivudine to telbivudine alone in patients with chronic hepatitis B.